Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Niewöhner
Maria Niewöhner, Wermelskirchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100016323 | 2-PHENYL SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS - The application claims a compound of the formula | 01-21-2010 |
| 20110009367 | 2-PHENYL SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS - The 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position are prepared from the corresponding 2-phenyl-imidazotriazinones by chlorosulphonation and subsequent reaction with the amines. The compounds inhibit cGMP-metabolizing phosphodiesterases and are suitable for use as active compounds in pharmaceuticals, for the treatment of cardiovascular and cerebrovascular disorders and/or disorders of the urogenital system, in particular for the treatment of erectile dysfunction. | 01-13-2011 |
Maria Niewöhner, Wermelskirchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100016323 | 2-PHENYL SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS - The application claims a compound of the formula | 01-21-2010 |
| 20110009367 | 2-PHENYL SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS - The 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position are prepared from the corresponding 2-phenyl-imidazotriazinones by chlorosulphonation and subsequent reaction with the amines. The compounds inhibit cGMP-metabolizing phosphodiesterases and are suitable for use as active compounds in pharmaceuticals, for the treatment of cardiovascular and cerebrovascular disorders and/or disorders of the urogenital system, in particular for the treatment of erectile dysfunction. | 01-13-2011 |
Sabine Niewöhner, Gutersloh DE
| Patent application number | Description | Published |
|---|---|---|
| 20110146107 | SKATE SHOE WITH BAYONET-LIKE CLOSURE MADE UP OF TWO HALF-AXES - A skate shoe includes a shoe having a sole through which runs a horizontal bore. From both sides of the horizontal bore of the sole, a half-axle is inserted with a wheel fixed at an outer end of each half-axle. The two half-axles have at least one flattened portion on their respective inner ends, which is located within the horizontal bore. The two flattened portions overlap within the bore and, in a second half of each flattened portion that is closer to the respective wheel, there is a recess. The each recess is complementary formed to a detent lug in a first half of the respective flattened portion and with the detent being able to pivot into the recess of the other half-axle. | 06-23-2011 |
Ulrich Niewöhner, Wermelskirchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100016323 | 2-PHENYL SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS - The application claims a compound of the formula | 01-21-2010 |
| 20110009367 | 2-PHENYL SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS - The 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position are prepared from the corresponding 2-phenyl-imidazotriazinones by chlorosulphonation and subsequent reaction with the amines. The compounds inhibit cGMP-metabolizing phosphodiesterases and are suitable for use as active compounds in pharmaceuticals, for the treatment of cardiovascular and cerebrovascular disorders and/or disorders of the urogenital system, in particular for the treatment of erectile dysfunction. | 01-13-2011 |
Ulrich Niewöhner, Wermelskirchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100016323 | 2-PHENYL SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS - The application claims a compound of the formula | 01-21-2010 |
| 20110009367 | 2-PHENYL SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS - The 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position are prepared from the corresponding 2-phenyl-imidazotriazinones by chlorosulphonation and subsequent reaction with the amines. The compounds inhibit cGMP-metabolizing phosphodiesterases and are suitable for use as active compounds in pharmaceuticals, for the treatment of cardiovascular and cerebrovascular disorders and/or disorders of the urogenital system, in particular for the treatment of erectile dysfunction. | 01-13-2011 |